Xenomics,
Inc.
420
Lexington Avenue, Suite 1701
New
York, New York 10170
March
16,
2006
VIA
FACSIMILE AND EDGAR
United
States Securities
and
Exchange Commission
100
F
Street, NE
Washington,
D.C. 20549
Attention:
William Bennett, Esq.
| Re: | Xenomics, Inc. | ||
| Registration Statement on Form SB-2 | |||
|
File
No. 333-127071
|
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of
1933, as amended (the “Act”), Xenomics, Inc. (the “Company”) respectfully
requests that the effective date of the registration statement referred to
above
be accelerated so that it will become effective at 4:00 p.m., Eastern Standard
Time, on Thursday, March 16, 2006, or as soon thereafter as possible. The
Company acknowledges that: 1) should the Commission or the staff, acting
pursuant to delegated authority, declare the filing effective, it does not
foreclose the Commission from taking any action with respect to the filing;
2)
the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company
from
its full responsibility for the adequacy and accuracy of the disclosure in
the
filing; and 3) the Company may not assert this action as defense in any
proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
|
XENOMICS,
INC.
|
||
| |
|
|
| By: | /s/ L. David Tomei | |
|
Name: L. David Tomei |
||
|
Title:
Chief Executive Officer
|
||